ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

NCI To Fund 3,232, Research Project Grants In Fiscal 1993

January 15, 1993

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012